跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
SFDA
/
Reblozyl
Authorized
BIOLOGICAL
Reblozyl
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
0f78e3a3e0ae04c8
Company
Unknown
Type
Biological
Approval Details
Approval Id
0f78e3a3e0ae04c8
Drug Approval Sfda Name
Reblozyl
Trade Name
Reblozyl
Generic Name
LUSPATERCEPT
Register Number
0109211004
Register Year
2021
Drug Type
Biological
Route Of Administration
Subcutaneous use
Package Type
Vial
Package Size
1
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
Store in a refrigerator (2°C – 8°C), do not freeze
Shelf Life
60 Months
Distribution Site
Hospital
Description Code
7000001785-25-100000073866
Price
7303
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
0f78e3a3e0ae04c8
Type
Biological
Back to SFDA Approvals
Reblozyl - SFDA Drug Approval Details